Introduction
Membrane proteins are generally inserted into the endoplasmic reticulum (ER) membrane by a co-translational mechanism, which begins with the association of signal recognition particle (SRP) to a hydrophobic sequence within the nascent polypeptide chain. This is followed by binding of the ribosome-nascent-chain-SRP complex to the SRP receptor on the ER membrane, and the delivery of the nascent chain to the Sec61 protein-conducting channel (Rapoport, 2007) . The well characterized co-translational pathway is, however, not accessible to the large and diverse group of membrane proteins that are classified as tail-anchored (TA) proteins.
TA proteins consist of a cytosolic N-terminal domain anchored to the membrane by a single transmembrane domain (TMD) close to the C-terminus. Different members of this group of proteins are found on essentially all membranes of the cell, where they have crucial roles in processes such as vesicular trafficking, protein translocation, and regulation of apoptosis (Borgese et al., 2003) . A recent bioinformatic analysis of the human genome has revealed the presence of 325 genes that code for 411 putative TA proteins (Kalbfleisch et al., 2007) , confirming the large size and functional importance of this group of membrane proteins.
To reach their correct destination within the secretory pathway, TA proteins, similarly to other membrane proteins, must first insert into the ER membrane (Jäntti et al., 1994; Kutay et al., 1995; Linstedt et al., 1995; Pedrazzini et al., 1996) . However, unlike the TMDs of other ER-directed membrane proteins, the TMD of TA proteins, because of its C-terminal position, remains sequestered within the ribosome and inaccessible to SRP and to the lipid bilayer until release of the completed polypeptide chain.
Thus, TA proteins are obliged to use a post-translational mechanism for their insertion into the ER membrane (Borgese et al., 2007; Borgese et al., 2003) .
In recent years, the introduction of new translocation assays, which distinguish between true transmembrane integration of TA proteins and their salt-resistant association to the cytosolic leaflet of the bilayer (Brambillasca et al., 2005) , has led to important advances in our understanding of the mechanisms used by this class of proteins to insert into the ER membrane. The analysis of the membrane components involved and of the energy requirements has revealed the existence of at least two insertion pathways. One group of TA proteins, which includes the translocon component Sec61β and the SNARE protein synaptobrevin 2, insert into the membrane by an assisted mechanism, meaning that they require energy and at least one proteinaceous component of the ER membrane High and Abell, 2004; Kim et al., 1997; Kutay et al., 1995) . Other TA proteins, such as the electron carrier cytochrome b5 (b5) and the protein tyrosine phosphatase (PTP)-1B, are instead able to translocate at nanomolar ATP concentrations into pure lipid vesicles, provided that these have low levels of cholesterol (Brambillasca et al., 2006; Brambillasca et al., 2005) . We have called this latter mechanism unassisted, meaning that the insertion does not depend on, and is not even facilitated by, any membrane protein, but not taking into consideration a possible requirement for cytosolic proteins. Access to, or exclusion from, the unassisted pathway is determined by the TMD of the TA substrate. Moderately hydrophobic and short TMDs can be inserted in an unassisted manner, whereas more hydrophobic ones require assistance (Brambillasca et al., 2006) . Tail-anchored (TA) proteins are membrane proteins that contain an N-terminal domain exposed to the cytosol and a single transmembrane segment near the C-terminus followed by few or no polar residues. TA proteins with a mildly hydrophobic transmembrane domain, such as cytochrome b5 (b5), are able to insert post-translationally into pure lipid vesicles without assistance from membrane proteins. Here, we investigated whether any cytosolic proteins are needed to maintain b5 in a competent state for transmembrane integration. Using b5 constructs translated in vitro or produced in bacteria, we demonstrate that cytosolic proteins are neither necessary nor facilitatory for the unassisted translocation of b5. Furthermore, we demonstrate that no cytosolic protein is involved in the translocation of a C-terminal domain of 85 residues appended to the transmembrane domain of b5. Nevertheless, b5 does bind cytosolic proteins, and in their presence but not in their absence, its insertion into liposomes is inhibited by the thiol oxidant diamide and the alkylating agent N-ethylmaleimide. The effect of diamide is also observed in living cells. Thus, the specific in vivo targeting of b5 might be achieved by interaction with redoxsensitive targeting factors that hinder its nonspecific insertion into any permissive bilayer.
In addition to investigations on the required membrane components, complementary studies have addressed the possible involvement of cytosolic proteins in the delivery of TA proteins to the ER. For the assisted pathway, a soluble receptor, named Asna1 or transmembrane recognition complex subunit of 40 kDa (TRC40) has recently been identified in the rabbit reticulocyte lysate (RRL). Asna1/TRC40 is an ATPase that recognizes the TMD of assisted TA proteins and delivers them to the ER membrane in an ATPdependent manner (Favaloro et al., 2008; Schuldiner et al., 2008; Stefanovic and Hegde, 2007) . However, it interacts poorly with the TMD of b5, and a dominant-negative mutant of the chaperone is ineffective on unassisted insertion (Stefanovic and Hegde, 2007) . Other studies have reported the involvement of Hsc70 and Hsp40 (Abell et al., 2007; Rabu et al., 2008) and SRP , suggesting that more than one assisted pathway might function in parallel.
The goal of the present study was to investigate the involvement of cytosolic proteins in the unassisted pathway of TA protein insertion. Indeed, a possible role for cytosolic chaperone(s), which could be required to keep 'unassisted' TA substrates in a translocation-competent conformation, was not excluded in previous studies (Brambillasca et al., 2006; Brambillasca et al., 2005) , and was in fact suggested in a recent report (Rabu et al., 2008) . To address this question, we have used b5 as representative of the unassisted class of TA proteins, and performed experiments both on the in vitro translated protein and on bacterially expressed purified constructs. Our results demonstrate that, although b5 binds to proteins present in the RRL, these proteins are neither necessary for, nor do they facilitate, transmembrane integration of b5. Nonetheless, oxidation of cytosolic proteins inhibits insertion both in vitro and in vivo, suggesting a regulatory role of chaperones in targeting and insertion. Quite remarkably, an 85-residue polar domain, appended to the C-terminus of b5, can be translocated into protein-free liposomes without assistance from any cytosolic protein or other lysate component.
Results

Cytosolic proteins are not required or facilitatory for the translocation of the b5 C-terminal polar domain
In a previous study (Brambillasca et al., 2005) , we developed a stringent assay that allowed us to evaluate true transmembrane integration of TA proteins. Briefly, b5 tagged with a C-terminal epitope derived from the N-terminus of bovine opsin (b5-ops28), is translated in vitro, incubated post-translationally with vesicles, and finally digested with proteinase K (PK). The generation of a 5 kDa protected fragment, consisting of the b5 TMD plus the 28 downstream polar residues, reports the translocation of the Cterminus of the tagged construct. In the case of insertion into ERderived vesicles, translocation is confirmed by the N-glycosylation of an acceptor site within the opsin sequence.
Using this assay, we demonstrated that b5-ops28 can efficiently integrate into pure lipid vesicles (unassisted translocation) (Brambillasca et al., 2006; Brambillasca et al., 2005) . To investigate the possible role of cytosolic proteins in the process, we first tested the effect of dilution of the RRL on translocation efficiency (Fig.  1A) . After translation of b5-ops28, the sample was diluted either in RRL or in a buffer (TB) permissive for translocation, with a resulting increase (lanes 1-3), or five (lanes 4-6) or ten (lanes 7-9) times lower RRL protein concentration during the subsequent incubation with or without liposomes. After 1 hour of translocation, an aliquot of each sample was directly analyzed by SDS-PAGE and autoradiography (-PK), whereas the remaining sample was digested with proteinase K (+PK) and immunoprecipitated. When liposomes were present, a protected fragment was generated that was destroyed if detergent was present during exposure to PK. The quantification of protected fragment band intensity normalized to protein load (-PK) indicated that reduction of RRL concentration did not affect translocation efficiency. Furthermore, the kinetics of b5-ops28 insertion under conditions of diluted or concentrated RRL were indistinguishable (Fig. 1B) .
The results of Fig. 1 suggest that, if a lysate protein is involved in b5 integration, it is either very abundant or has such a low dissociation rate from b5 as to be insensitive to dilution. To distinguish between these possibilities, we turned to a purified In vitro translated b5-ops28 was either diluted in RRL (lanes 1-3, final lysate protein concentration 90 mg/ml), or in TB with a final lysate protein concentration of 18.5 mg/ml (lanes 4-6) or 7 mg/ml (lanes 7-9). The diluted samples were incubated with or without PC liposomes (lipo) for 1 hour at 32°C as indicated. An aliquot of each sample was left untreated (top, -PK) whereas the remaining was digested with PK in the absence or presence of 0.2% Triton X-100. The % translocation efficiency relative to the value obtained with concentrated lysate, taken as 100%, is indicated below the lanes. (B) Time course of translocation of b5-ops28 in diluted or undiluted RRL. Translated b5-ops28 diluted in lysate or in TB (90 or 18.5 mg/ml final lysate protein concentration, respectively) was incubated with PC liposomes for the indicated times. b5-ops28 whose insertion into liposomes could be followed in the absence of any RRL component. b5-ops28, produced as a glutathione-S-transferase (GST) fusion protein (see supplementary material Fig. S1 ) and bound to glutathione (GSH)-Sepharose, was eluted from the resin by thrombin cleavage either in the presence or in the absence of RRL. As shown in supplementary material Fig.  S2A , the resulting b5-ops28 sample was of high purity and was devoid of visible contamination by bacterial proteins. To evaluate translocation, we adapted the protease protection assay to the bacterially expressed protein, revealing the protected fragment by western blotting with anti-opsin monoclonal antibodies (mAbs). After incubation of b5-ops28 with liposomes, and digestion in the absence of detergent, a protected fragment was detected, both in the presence and in the absence of RRL ( Fig. 2A, lanes 2 and 5) . The percentage of translocation ( Fig. 2A ) and the kinetics of the insertion (Fig. 2B ) of b5-ops28 in the absence or presence of RRL were indistinguishable. Thus, b5-ops28 inserts efficiently into vesicles of pure lipids independently of any protein, nucleotide or other lysate component.
An 85-residue peptide, appended to the TMD of b5, can be translocated across protein-free liposomes in the absence of any cytosolic protein
In a previous study, we investigated the limits of the unassisted insertion pathway and found that polar sequences of up to nearly 100 amino acids placed downstream to the TMD of b5 could be post-translationally translocated into protein-free liposomes after in vitro translation in the RRL (Brambillasca et al., 2006) . We asked whether such long polar domains could also be translocated in the absence of cytosolic proteins. To this end, we expressed in bacteria a fusion protein of GST and b5-ops85 (see supplementary material Fig. S1 ), a construct derived from b5, in which the C-terminal polar domain was increased to 85 residues (Brambillasca et al., 2006) . b5-ops85, cleaved from GST in the presence of RRL or buffer (Fig. 3A) , was incubated either with pig pancreas microsomes (MRs) or liposomes and then subjected to the protease protection assay. Remarkably, as demonstrated by a protected fragment of the expected size that was digested in the presence of detergent, b5-ops85 was able to translocate into both MRs and liposomes, regardless of the presence or absence of lysate proteins. After incubation with MRs, a minor, higher M r band was generated (Fig. 3A , asterisk in lanes 2 and 7) that corresponds to the glycosylated protected fragment, as demonstrated by its disappearance when an inhibitory tripeptide was present during the translocation reaction (not shown). The low glycosylation efficiency compared with that observed with the in vitro translated protein (Brambillasca et al., 2006) can be explained by the higher substrate load imposed with the purified protein used in the assay.
Since the N-terminal catalytic domain of b5 is not much longer than the C-terminal polar sequence of b5-ops85 (109 versus 85 residues), we asked whether a portion of the lengthened construct could translocate with the opposite topology. After protease protection, blots containing the digested and undigested samples were therefore probed both with the anti-opsin mAb and with antib5. As shown in Fig. 3B , lane 2, only the C-terminal domain was translocated, as revealed by the protected fragment detected with the anti-opsin mAb. By contrast, the anti-b5 antibody failed to reveal a protected fragment in the translocated sample (Fig. 3B , lane 5). Only a small amount of PK-resistant core (Fig. 3B , arrowhead) could be detected, which was present regardless of the incubation with liposomes or of the presence of detergent during digestion.
Finally, we compared the insertion efficiency of b5-ops85 with that of b5-ops28 and established the protein to lipid molar ratio in the resulting proteoliposomes. Translocation reactions were carried out with known amounts of the two proteins and of lipid vesicles, and translocation efficiency was calculated taking into account differences in the efficiency of blotting or of immunoprecipitation between the intact protein and the protected fragments and possible incomplete protection from the PK digestion (see legend to supplementary material Fig. S2 ). As shown in Fig. 3C , b5-ops28 had a concentration in reconstituted proteoliposomes comparable with that of endogenous b5 in liver MRs, where the cytochrome represents ~1% of all protein (Omura and Takesue, 1970) . b5-ops85 showed an insertion efficiency about five times lower than b5-ops28, in agreement with our previous results on the in vitro translated proteins (Brambillasca et al., 2006) . 
b5 interacts with cytosolic proteins via its TMD
Although the above results demonstrate that cytosolic proteins are not required for insertion of b5, we hypothesized that it might nonetheless bind to chaperones that could be involved in its specific in vivo targeting (Borgese et al., 2001; D'Arrigo et al., 1993; De Silvestris et al., 1995) . To evaluate possible interactions of b5-ops28 with cytosolic proteins, we first compared the sucrose gradient sedimentation profiles of the protein eluted in the presence or absence of RRL (Fig. 4A) . Under both conditions, b5-ops28 was recovered in high M r complexes. However, the patterns obtained after elution under the two conditions were different. In agreement with previous reports on b5 (Spatz and Strittmatter, 1971) , b5-ops28 eluted in buffer alone self-associated into oligomers of heterogeneous size up to 240 kDa. In the presence of RRL, the sedimentation profile was shifted to the lower M r region of the gradient, with two major peaks (fractions 3 and 6) in the ~60,000 to 10,0000 region, indicating an association of b5-ops28 with one or more RRL proteins.
In an attempt to identify these proteins, we probed for the binding of known chaperones reported to be involved in the insertion of TA proteins that follow the assisted pathway Abell et al., 2007; Stefanovic and Hegde, 2007) . GST-b5 or a truncated construct lacking the TMD (GST-b5-ΔTMD) (supplementary material Fig. S1 ) immobilized on GSH-Sepharose were incubated with RRL, and fractions of bound and unbound proteins were separated. These were probed with antibodies against Hsc70, Hsp40, SRP54 and TRC40. As shown in Fig. 4B , Hsc70 strongly bound to b5 and to a lesser extent to b5-ΔTMD. Binding of SRP54 and Hsp40 was close to undetectable, whereas TRC40
Journal of Cell Science 122 (14) Fig. 3 . The 85-residue C-terminal domain of b5-ops85 can be translocated in the absence of any RRL component. (A) Bacterially expressed b5-ops85, cleaved from GST in the absence or presence of RRL, was incubated with pig pancreas MRs or liposomes. After translocation, the samples were PK digested in the presence or absence of 0.2% Triton X-100. Asterisks indicate the glycosylated protected fragment generated after translocation into MRs but not into liposomes. (B) Only the C-terminal domain of b5-ops85 produced in bacteria is translocated across liposomes. Bacterially expressed b5-ops85, cleaved in the absence of RRL and incubated with liposomes, was subjected to PK digestion in the absence or presence of detergent, as indicated. Each sample was divided into two, and probed with the anti-opsin mAb (lanes 1-3) or with a polyclonal anti-b5 antibody (lanes 4-6). The arrowhead indicates the protease-resistant core of b5. (C) 22.5 pmol b5-ops28 or b5-ops85 produced in bacteria and eluted in PBS were incubated with liposomes (12 nmol PC). After translocation, samples were digested with PK and immunoprecipitated. The protein:lipid molar ratio in the liposomes after translocation, calculated as described in the Materials and Methods is shown for the two proteins. (B) Analysis of the TMD-dependent interaction of RRL proteins with b5 by pull-down assays. b5 or a truncated version thereof, consisting of the catalytic domain of b5 without the TMD (b5-ΔTMD), produced in bacteria as GST fusion proteins were bound to GSH-Sepharose. Equivalent aliquots of the bound (B) and unbound (U) fractions as well as of total (T) RRL were analyzed by immunoblotting with the indicated antibodies.
showed clear, TMD-dependent binding, in agreement with a previously observed weak crosslinkage of this chaperone to b5 (Stefanovic and Hegde, 2007) .
Oxidizing conditions and alkylation of sulfhydryl groups of cytosolic proteins inhibit b5 transmembrane insertion
Maintenance of the reduced state of cysteine residues is important for the functionality of many cytosolic proteins. We hypothesized that oxidation of the cytosolic proteins with which b5 interacts might alter its delivery to the bilayer, and took advantage of the absence of cysteine residues in b5-ops28 to investigate the effect of alkylating or oxidizing agents on its insertion. As shown in Fig.  5A , after oxidation with the thiol oxidant diamide (DIA) (Kosower and Kosower, 1995) , translocation of the in vitro translated protein was almost completely blocked (Fig. 5A, lane 3) . The effect of oxidation could be neutralized when GSH was added during exposure to DIA (Fig. 5A , lane 5, GSH-co) and, importantly, was reversed if GSH was added after treatment with DIA (Fig. 5A , lane 4, GSH-post). By contrast, addition of ATP did not reverse the inhibition, and incubation with DIA after translocation had no effect on generation of the protected fragment (not shown), indicating that oxidation did not affect the integrity of the liposomes.
A pronounced but weaker inhibition (~60%) was also obtained by alkylation with N-ethylmaleimide (NEM), which was neutralized by addition of dithiothreitol (DTT), together with NEM (Fig. 5B) . As in the case of DIA, addition of ATP after NEM treatment did not reverse the inhibition (not shown).
To investigate whether DIA and NEM are also inhibitory on other unassisted proteins, we tested the effect of these compounds on PTP-1B, which inserts by the same pathway as b5 (Brambillasca et al., 2006) . After in vitro translation, insertion of PTP-1B was indeed inhibited by DIA (supplementary material Fig. S3 ) and by NEM (not shown), indicating that the effects of oxidation and alkylation are not a peculiarity restricted to b5 insertion.
We next confirmed the lysate-dependence of the NEM and DIA effects on insertion by using bacterially expressed b5-ops28. b5-ops28, cleaved from GST in the presence of RRL, bovine serum albumin (BSA) or buffer, was treated either with NEM or with DIA. DIA inhibited translocation in the presence of RRL, but not when b5-ops28 was eluted and translocated in the presence of buffer alone, or when BSA was present during both elution and the subsequent incubation with liposomes (Fig. 6A) . Interestingly, DIA was ineffective if allowed to act before incubation with b5-ops-28 (pretreated lysate) (Fig. 6B) , indicating that the oxidant is effective on pre-formed complexes involving the cytosolic partners in the reduced state (Fig. 6B) . Analogously to DIA, the inhibitory effect of NEM was observed only when RRL was present and not when the protein was eluted in PBS (Fig. 6C) .
Since no cytosolic protein is required for b5 insertion (Figs 1  and 2 ), the effects of oxidation and alkylation are probably due to trapping of b5 in an unproductive complex with oxidized protein(s). In support of this, we found that addition of fresh lysate to NEMtreated samples did not restore translocation competence to b5-ops28 (supplementary material Fig. S4A ), and that after NEM or DIA treatment, more of the in vitro translated protein was recovered in a high-speed pellet than in the untreated samples (supplementary material Fig. S4B ). However, most of the b5-ops28 also remained in the supernatant under these conditions, indicating that gross aggregation cannot account for the translocation inhibition.
To further characterize the trapping phenomenon, we investigated whether the chaperones analyzed in the pull-down assays of Fig. 4 showed increased binding to b5 in the presence of DIA. We found no difference for Hsp40 and SRP54 (not shown), but a slight increase in TRC40 binding (supplementary material Fig. S5 ). We therefore immunodepleted TRC40 and Hsc70 (which shows strong binding also in the absence of DIA) (Fig. 4B) from the RRL and then compared the inhibitory effects of DIA in the presence of untreated or depleted lysate. As shown in Fig. 7A (left panel), our antibodies were efficient in depleting TRC40 from the RRL under native conditions. Hsc70 depletion was also significant (~70%), although less complete (Fig. 7C) . To assess the functional significance of the TRC40 depletion, we compared the translocation efficiency of in vitro translated b5 and a b5 construct (b5-Syb2-ops28) (supplementary material Fig. S1 ) with the TMD of synaptobrevin 2 (Syb2 or VAMP2). This construct, like Syb2 itself, follows the assisted pathway (Brambillasca et al., 2006) . As expected from the work of (Stefanovic and Hegde, 2007) , TRC40 depletion had no effect on b5-ops28 transmembrane integration, but caused reduced (by ~45%) integration of the chimera (Fig. 7A,  right) .
We then compared the effect of oxidation of both the in vitro translated and of the bacterially produced b5-ops28 in untreated and depleted lysates. As shown in Fig. 7B , DIA was equally effective in ΔTRC40 and undepleted RRL. Likewise, the 70% depletion of Hsc70 did not affect DIA-mediated inihibition. These results suggest that proteins other than TRC40 and Hsc70 mediate the inhibitory effect of the oxidant on b5 insertion.
DIA also inhibits b5 insertion in vivo
To reveal a possible regulatory role of redox conditions on TA protein insertion, we investigated the effect of DIA on b5 insertion in intact cells. Since protein synthesis is inhibited by DIA, we injected the purified bacterially expressed protein into the cytosol of cultured cells. Cells were then returned for 15 minutes to the incubator, in the presence or absence of DIA and then fixed. In the absence of DIA, b5-ops28 showed the typical ER immunostaining pattern for b5, which coincided with that of calnexin (Fig. 8Aa-c) and not with mitochondrial staining (Fig. 8Ba-c) . Thus, microinjected b5 is targeted in the same way as the protein produced within cells. DIA treatment caused a dramatic shift in the localization of microinjected b5, which now yielded a diffuse staining pattern, consistent with a cytosolic localization (Fig.  8A ,Bd-f), thus recapitulating the insertion inhibition observed in vitro.
Discussion
Because of their peculiar topology, TA proteins are obligatorily inserted into the ER membrane by a unique post-translational mechanism that recent studies are beginning to clarify (reviewed by Borgese et al., 2007) . There is now general agreement that different TA proteins have different requirements for insertion ) depending on features of the TMD (Brambillasca et al., 2006; Rabu et al., 2008) . More specifically, most TMDs require an ER membrane protein for integration (assisted pathway), but moderately hydrophobic and short ones, similar to that of b5, can translocate their C-terminus across protein-free lipid bilayers (Brambillasca et al., 2006; Brambillasca et al., 2005) . Although we refer to this latter mechanism as non-assisted, our previous studies did not exclude a role in this pathway for cytosolic proteins, which might be needed to keep the TA substrate in a state competent for delivery to the bilayer. This question has been addressed in the present investigation.
b5 binds to cytosolic proteins, but these do not facilitate its transmembrane integration
Recent studies have identified a cytosolic ATPase (Asna1/TRC40) in the ATP-dependent pathway of delivery of a number of TA substrates to the ER membrane, both in mammals (Favaloro et al., 2008; Stefanovic and Hegde, 2007) and in yeast [where it is called Get3 (Schuldiner et al., 2008) ]. However, this protein appeared not to be involved in the delivery of b5 to the ER membrane (Stefanovic and Hegde, 2007) , and whether other cytosolic proteins were involved was unclear. A recent study (Rabu et al., 2008) reported that in vitro insertion of puromycin-released truncated TA polypeptides with moderately hydorophobic TMDs (b5, PTP-1B, and bcl2) is strongly facilitated by Hsc70/Hsp40. However, transmembrane integration of b5-ops28 in the RRL occurs at ATP concentrations as low as 3 nM and is not stimulated by re-addition Journal of Cell Science 122 (14) -8) , or a 100 mg/ml solution of BSA (lanes 9-16) or PBS (lanes 17-20). 2.5 μl of the eluted protein was diluted in RRL or PBS to the indicated final protein concentration. After incubation with DIA, the samples were supplemented with GSH and then liposomes, as indicated above the lanes. (B) RRL pre-treated with DIA before exposure to b5 is ineffective in inhibiting translocation. b5-ops-28 produced in bacteria and eluted with thrombin in PBS was diluted ten times, either in untreated RRL (lanes 1-4) or in RRL pretreated with DIA (lanes 5-6) or pre-treated with DIA and then incubated with GSH (lanes 7-8). The samples diluted in untreated RRL were then incubated with DIA followed or not by GSH, as indicated. The panel shows the protected fragments obtained after translocation into PC liposomes and PK digestion. (C) Inhibition by NEM occurs only in the presence of lysate. b5-ops28 produced in bacteria and eluted with thrombin in the presence or absence of RRL was incubated with or without 20 mM NEM in the presence or absence of DTT, as indicated. Samples were incubated with or without liposomes and analyzed by protease protection. Tail-anchored protein biogenesis of nucleotides (Brambillasca et al., 2006) . This observation is difficult to reconcile with an insertion mechanism mediated by DnaK proteins, whose K m for ATP is in the micromolar range (Braell et al., 1984) .
To resolve the question of the role of chaperones in b5 insertion, we turned to a simplified system consisting of a purified preparation of b5 produced in E. coli. The purified protein could be integrated into liposomes with high efficiency, and, importantly, the efficiency and time course of its insertion were the same in buffer alone or in the presence of RRL. Notably, we found that even a polar stretch of 85 residues appended to the TMD of b5 could be translocated across protein-free bilayers in the absence of any cytosolic factor, extending the significance of our previous study on the in vitro or in vivo expressed lengthened construct (Brambillasca et al., 2006) . We conclude that b5 [and presumably other unassisted proteins, such as PTP-1B (Brambillasca et al., 2006) ], can integrate into lipid bilayers without any assistance from, or even facilitation by, either membrane or cytosolic proteins, Notwithstanding the absence of any requirement for chaperones, several observations of this study indicate that b5 does interact, via its TMD, with more than one cytosolic protein. Sucrose gradient analysis demonstrated a change in the sedimentation profile of purified b5-ops-28 in the presence of RRL, and pull-down assays showed that b5 binds both Hsc70 and TRC40. Furthermore, in the presence of RRL, alkylating (NEM) and oxidative (DIA) agents inhibited b5 insertion. A recent paper has reported inhibition of transmembrane integration of the assisted TA proteins, RAMP4 and Sec61β, but not of b5, by oxidation and alkylation (Favaloro et al., 2008) . The discrepancy between these and our results might be explained by the type of oxidants and the NEM concentration used in that study, as well as in other differences in experimental procedure.
Of the two tested inhibitory compounds, DIA had the most striking effect, inducing a near complete, RRL-dependent translocation block, which could not be correlated with gross aggregation of the TA substrate and which was nearly fully reversible. The effect of NEM was less pronounced, and we do not know at present whether or not alkyation and oxidation affect the same protein. Very interestingly, we found that DIA also acts within living cells, indicating that the observed effect does not specifically require reticulocyte proteins. In an attempt to identify the cytosolic proteins responsible for the inhibition, we considered TRC40 and Hsc70, because pull-down experiments had shown that they both bind to the b5 tail. However, strong depletion of these chaperones from the RRL did not affect the translocation block obtained with DIA, suggesting that they do not mediate the inhibition.
Although the protein(s) through which DIA mediates its inhibition remain to be identified, the most likely mechanism consistent with the cytosol-independence of b5 insertion is a redox-induced trapping phenomenon. We hypothesize that an altered conformation of one or more of the binding partners of b5 results in the formation of an unproductive complex incapable of releasing the substrate to the membrane. A similar trapping mechanism might also explain the recent results of Rabu and colleagues (Rabu et al., 2008) . These authors observed inhibition of b5 (as well as of PTP-1B and bcl2) insertion by small molecule inhibitors of Hsp40/Hsc70, in parallel with the formation of b5-containing Hsp40/Hsc70 aggregates. Fig. 9 depicts three pathways by which b5 can insert into the lipid bilayer, revealed by our results. In the absence of cytosol (Fig.  9, pathway 1) , b5 self-associates via its TMD (as demonstrated by sucrose gradient analysis), but we suggest that it can be released from these oligomers in an insertion-competent form, which we have depicted as a monomer. In the presence of RRL, de novo synthesized b5 interacts with one or more cytosolic proteins (Fig.   Fig. 7 . TRC40 and Hsc70 depletion of RRL do not alter the inhibitory effect of DIA. (A) TRC40 depletion of RRL. Left: after TRC40 depletion, equal aliquots of untreated or depleted (ΔTRC40) lysate were analyzed by western blotting with anti-TRC40 antibodies. Right: Untreated or ΔTRC40 lysates were used to translate b5-ops28 or a b5 chimera, containing the TMD of synaptobrevin 2 (b5-Syb2-ops28). The translated proteins were allowed to translocate into MRs. The protected fragments obtained after PK digestion are shown. (B) DIA inhibits translocation of b5-ops28 in ΔTRC40 lysate. b5-ops28 was translated in untreated (lanes 1-4) or in ΔTRC40 lysate (lanes 5-8). The bacterially produced fusion protein was eluted with thrombin in the presence of untreated or depleted lysate (lanes 9-12 and 13-16, respectively). Samples were subjected to incubation with DIA, or DIA plus GSH as indicated, followed by translocation into liposomes. (C) Hsc70 depletion of RRL. Equal aliquots of untreated or depleted (ΔHsc70) lysate were analyzed by western blotting with anti-Hsc70 antibody. (D) DIA inhibits the translocation of b5-op-28 into liposomes in the presence of ΔHsc70 lysate. b5-ops-28 produced in bacteria was eluted with thrombin in the presence of untreated or ΔHsc70 lysate (lanes, 1-4 and lanes 5-8, respectively) and analyzed as described in B.
9, pathway 2) from which it can be released at very low ATP concentrations [3 nM (Brambillasca et al., 2006) ] to converge onto the spontaneous insertion pathway followed in the absence of cytosol. Oxidation of the interacting protein(s), both in vivo and in vitro, causes a conformational transition that results in trapping of the TA substrate in a non-productive complex (Fig. 9, pathway 3) . Thus, cytosolic factors might have a regulatory role, modulating the delivery of non-assisted TA proteins to the appropriate lipid bilayer in response to altered conditions in the cytosol.
The targeting problem
Unassisted insertion has been reported not only for ER-targeted TA proteins, but also for some that insert into the outer mitochondrial membrane and peroxisomes (Kemper et al., 2008) , as well as in the outer chloroplast envelope (Qbadou et al., 2003) . For instance, in vitro synthesized Fis1, a fission protein shared by mitochondria and peroxisomes (Mozdy et al., 2000; Schrader, 2006) , can insert similarly to b5, into protein-free lipid vesicles (Kemper et al., 2008) . Furthermore, cytosolic proteins appear to be dispensable for insertion of a number of outer mitochondrial membrane TA proteins, both in cell-free systems with purified mitochondria (Lan et al., 2000) and in digitonin-permeabilized cultured cells (Setoguchi et al., 2006) . How then is specificity in targeting of these proteins achieved in vivo? Lipid composition, such as low sterol content (Brambillasca et al., 2005; Kemper et al., 2008) might broadly determine which membranes are competent for spontaneous TA protein integration; however, because the sterol content of the ER, the OMM and the peroxisomal membrane are similarly low, additional factors must determine the discrimination between these two organelles. It is plausible that cytosolic targeting factors play this role. In agreement, a recent study has revealed that Fis1 targeting to peroxisomes is mediated by the peroxisomal membrane protein import factor Pex19 (Delille and Schrader, 2008) . On the basis of the results presented in this study, however, in the case of the nonassisted TA proteins, such targeting factors must have a dual role, preventing spontaneous insertion and favouring delivery to the correct target (hypothetical pathway 4 in Fig. 9) .
Much of the difficulty in understanding the targeting mechanisms of unassisted TA proteins has been due to the lack of recapitulation of their in vivo targeting specificity in in vitro systems (e.g. Borgese et al., 2001) . The lack of specificity in cell-free systems can now be rationalized by postulating that, under in vitro conditions, binding of unassisted TA substrates to targeting factors is too weak to be effective, so that integration into any bilayer of appropriate lipid composition can occur (pathway 2 in Fig. 9 ). Appropriate in vivo and in vitro assays, based on the knowledge of the totally unassisted insertion pathway described here, will hopefully lead to the unravelling of the mechanisms underlying the specific targeting of this class of TA proteins.
Materials and Methods
Plasmids and antibodies
The constructs used in this study (illustrated in supplementary material Fig. S1 ) were generated by standard recombinant DNA techniques and checked by sequencing. The construct PTP1B-ops-35, containing the coding sequence of PTP1B and the opsin tag is described (Brambillasca et al., 2006) . A polyclonal antibody against rabbit TRC40 was generated by immunizing rabbits with a peptide corresponding to the Cterminal region (from residues 84 to 100) conjugated to Keyhole Limpet Hemocyanin.
Journal of Cell Science 122 (14) Fig. 8 . DIA inhibits b5-ops28 insertion into the ER membrane in vivo. b5-ops28, purified from bacteria, was microinjected into the cytosol of CV-1 cells. The cells were then incubated for 15 minutes at 37°C in the presence or absence of 2 mM DIA as indicated. Cells were then fixed, and b5-ops28 was revealed using the anti-opsin mAb, as indicated. The ER and mitochondria in the same cells were revealed with anti-calnexin (A) and anti-complex III (B). Cells were imaged by confocal microscopy. The merged images for each field, with the indicated pseudocolors, are shown in the right column (c,f). 35 out of 40 observed microinjected cells incubated without DIA showed the typical ER staining pattern for b5 illustrated in panels a of A and B. 100% of the observed DIA-treated cells (20 cells) exhibited the illustrated diffuse staining (d). Scale bars: 10 μm. Fig. 9 . Proposed pathways for the post-translational insertion of b5 into lipid bilayers. In the absence of cytosolic proteins, b5 self-associates via its TMD (in red), but it can be released to insert spontaneously into the lipid bilayer (Pathway 1). b5 does, however, associate via its TMD with cytosolic proteins, from which it can dissociate to converge onto the spontaneous insertion pathway (Pathway 2). It is possible that these cytosolic proteins have a role in specifically delivering b5 to the ER in vivo (Pathway 4; the dashed line indicates that the pathway is hypothetical). Oxidation or alkylation induces a conformational change in the cytosolic binding partners of b5, which results in trapping of b5 in an unproductive complex both in vitro and in vivo (Pathway 3). Tail-anchored protein biogenesis A specific 40 kDa band, absent in blots probed with pre-immune serum, was recognized by the anti-TRC40 antibody in western blots both of RRL and of rat liver MRs. The antibody was also efficient in immunoprecipitating TRC40 under native conditions. Anti-b5 polyclonal antibody was present in our laboratory (Borgese et al., 2001 ). Anti-bovine opsin mAb R2-15 and anti-SRP54 polyclonal antibodies were from Paul Hargrave (Adamus et al., 1991) and Bernhard Dobberstein (University of Heidelberg, Heidelberg, Germany), respectively. Hsc70 rat mAbs and Hsp40 polyclonal antibodies were from Stressgen.
Translocation assay of in vitro synthesized b5-ops28
Transcription and translation of pGEM4-b5-ops28 in the RRL (Promega), translocation reactions with total rat liver MRs, prepared by differential centrifugation, pig pancreas MRs (Brambillasca et al., 2005) or liposomes, prepared by extrusion of bovine liver phosphatidylcoline (PC) (Avanti Polar Lipids) suspensions, were performed as previously described (Brambillasca et al., 2005) . For a standard translocation reaction 2.5-5 μl translated product was incubated with 9 μg PC liposomes in a 10 μl final reaction. In some experiments, translation products were diluted in a buffer (translocation buffer, TB) containing 50 mM HEPES-K + pH 7.2, 250 mM sorbitol, 70 mM potassium acetate, 5 mM K + EGTA, 2.5 mM magnesium acetate and 4 mM DTT before carrying out the translocation reaction. The concentration of PC liposomes was determined by including a known amount of radioactive PC as tracer. The protease protection assay to detect the translocated portion of the opsin-tagged constructs, immunoprecipitation of the intact protein or the protected fragment with anti-opsin mAbs, and analysis of the protected fragments on Tris-Tricine gels have been described in detail (Brambillasca et al., 2005) .
To block sulfhydryl groups of RRL proteins, in vitro translated samples were incubated with 20 mM NEM (diluted from a freshly made 0.5 M solution in ethanol) for 30 minutes at 32°C. After quenching the NEM with 40 mM DTT for 10 minutes at 32°C, liposomes were added and incubation was continued for 1 hour at 32°C. To assay for translocation under oxidizing conditions, the translation mixture was incubated for 30 minutes with 5 mM DIA at 32°C before addition of vesicles. To revert the effect of DIA, 20 mM GSH was added either during (GSH-co) or after (GSH-post) exposure to DIA. In the latter case, incubation was continued for 20 minutes before the addition of vesicles.
Radioactive gels were imaged with the Storm phosphoimager (GE-Healthcare) and band intensities quantified with ImageQuant software. The percentage of translocation in liposomes was calculated from the quantification of the percentage of glycosylation of a parallel sample translocated into MRs and comparison between the protected fragments generated with liposomes and MRs, as previously described (Brambillasca et al., 2005) .
Purification of b5, b5-ΔTMD, b5-ops28 and b5-ops85 expressed as fusion proteins in bacteria bl21 bacteria, transformed with plasmids coding for GST fusion proteins with the different b5 forms, and induced for 4 hours with 0.5 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG), were collected from 1 liter cultures and lysed with 80 ml of buffer containing 2% Triton-X 100, 150 mM NaCl, 25 mM Tris-HCl pH 7.4, 10 mM EDTA, 0.2 mg/ml lysozyme, 10 mg/ml DNase, plus a protease inhibitor mixture. After incubation for 3-5 hours at room temperature, the lysate was clarified by centrifugation (10,000 ϫ g for 40 minutes at 4°C) and the soluble fraction was aliquoted and conserved at -80°C. To purify the b5 proteins, the corresponding soluble fraction was incubated overnight at 4°C on a rotating wheel with GSH-Sepharose 4B beads (GE-Healthcare, 40 μl of a 50% resin suspension per 300 μl soluble fraction plus 700 μl lysis buffer). After removing unbound material, the beads were incubated with 100 μl of a solution containing 2 mM ATP, 10 mM MgSO 4 , 50 mM Tris-HCl (pH 7.4) for 10 minutes at 37°C, to remove associated chaperones. The beads were then washed once with PBS plus 1% Triton X-100 followed by ten washes with PBS without detergent. The b5 constructs were then released by incubation for 40 minutes at room temperature with 0.5 U thrombin diluted in 20 μl of either PBS, RRL or BSA solution (100 mg/ml in PBS). The yield of the thrombin cleaved protein was evaluated by the Lowry assay or by comparison of its Coomassie blue staining with that of known amounts of BSA after SDS-PAGE analysis.
Translocation of b5 constructs purified from bacteria
For a standard translocation reaction 1.5-3 μl of the purified protein described in the preceding paragraph (corresponding to 50-500 ng) was incubated with 9 μg PC liposomes in a 10 μl final volume. The translocation and protease protection assay followed by antiopsin immunoprecipitation was performed as described for the radioactive translation product, except that the PK concentration was 0.5 mg/ml. NEM or DIA treatment were performed as described for the in vitro translated product.
After translocation, the samples were analyzed by SDS-PAGE on 13% Tris-tricine gels, followed by blotting onto nitrocellulose (0.22 pore size, GE Healthcare) and the intact protein or the protected fragment were revealed by enhanced chemiluminescence with Pico reagents (Pierce) using the antiopsin mAb or anti-b5 polyclonals. The films were digitized and band intensities determined with the ImageJ software after calibration with the optical density calibration step table (Stouffer Graphics Arts, Mishawaka, IN). Since the opsin tag is present both on the intact protein (-PK) and on the protected fragment (+PK) the ratio of band intensities in the digested versus the undigested polypeptide reflects the molar percentage of translocation (see supplementary material Fig. S2 for details) .
Velocity sucrose gradient centrifugation b5-ops28 was produced in bacteria and eluted from GSH-Sepharose beads with thrombin in PBS or in RRL. A 15 μl sample was diluted in 185 μl of a buffer containing 20 mM NaCl and 25 mM Tris-HCl pH 7.4, and loaded on top of a 12 ml 5-20% linear sucrose gradient containing the same salts, in tubes of the SW40 rotor (Beckman Instruments), which were centrifuged at 100,000 ϫ g for 16 hours at 4°C. Markers for sedimentation rates (cytochrome c, BSA, rat IgG and catalase) were run on a separate gradient centrifuged in parallel. 15 fractions were collected from the top with an Auto Densiflow probe (Buchler Instruments) and subjected to precipitation with TCA in the presence of 75 μg cytochrome c as carrier. The precipitated proteins were analyzed by SDS-PAGE on 13% Tris-glycine gels followed by western blotting, using the R2-15 mAb against the opsin tag.
Pull-down assays
GSH resin (30 μl) was incubated overnight at 4°C on a rotating wheel with 500 μg GST-b5 or GST-b5 ΔTM. After removing unbound material, the beads were treated to detach associated chaperones and washed to remove any detergent trace. The beads were then incubated with 30 μl RRL in the presence or absence of 5 mM DIA for 30 minutes at 32°C. After the removal of the unbound proteins (U), the beads containing bound (B) RRL proteins, were subjected to thrombin cleavage to avoid interference of the fusion proteins with the subsequent western blotting analysis. Equivalent aliquots of the bound and unbound fractions as well as of total (T) RRL were analyzed by immunoblotting.
TRC40 and Hsc70 lysate depletion
Protein-G-Sepharose (35 μl) was incubated with 15 μl anti-TRC40 antibody (IgG purified 20 mg/ml) or 40 μl Hsc70 mAb (0.5 mg/ml) plus 1 μl RNasin (Promega) for 1 hour at 4°C. After removing the supernatant, the resin was incubated with 35 μl RRL and 1 μl RNasin for 1 hour at 4°C, and the depleted lysate was recovered after centrifugation.
Microinjection and treatment of cells with DIA
Purified bacterially produced b5-ops28 (250 ng/μl) eluted in PBS was injected into the cytosol of CV1 cells with a microinjector (Eppendorf 5200), applying a pressure of 80-90 hPa. The microinjected cells were returned to the incubator in complete medium supplemented or not with 2 mM DIA and fixed 15 minutes later.
